GPR55 and glioblastoma: GPR55 expression negatively correlates with survival in patients with glioblastoma, breast cancer, and PDAC10,14,15, and genetic ablation of Gpr55 significantly prolonged survival in the KPC transgenic mouse model of PDAC15.